BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17459213)

  • 1. [Effects of controlled-release arsenic-trioxide-eluting stents on in-stent neointimal hyperplasia in coronary artery: experiment with dog model].
    Zhao JL; Sun BG; Wen QZ; Zhang JJ; Jin W; Xue JX; Zhuang WY
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):567-9. PubMed ID: 17459213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of early and non-early controlled-release of arsenic-trioxide eluting stents on restenosis inhibition in a canine model].
    Zhao JL; Sun BG; Wen QZ; Zhang JJ; Jin W; Xue JX; Zhuang WY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):571-4. PubMed ID: 17711724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of control-releasing arsenic trioxide-eluting stent on intimal smooth muscle cells and type III collagen in canine coronary artery post-stent model].
    Zhao JL; Sun BG; Wen QZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):636-9. PubMed ID: 20815282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model.
    Shen L; Gong F; Tian W; Li W; Zhang F; Qian J; Sun A; Zou Y; Yang W; Ge J
    Biomed Res Int; 2013; 2013():937936. PubMed ID: 23509814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arsenic trioxide eluting stents to prevent restenosis of injured iliac arteries in rabbits].
    Yang W; Ge JB; Liu HL; An Y; Liu XB; Tian Y; Qu XF; Li WM; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):14-8. PubMed ID: 16626542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
    Serruys PW; Sianos G; Abizaid A; Aoki J; den Heijer P; Bonnier H; Smits P; McClean D; Verheye S; Belardi J; Condado J; Pieper M; Gambone L; Bressers M; Symons J; Sousa E; Litvack F
    J Am Coll Cardiol; 2005 Jul; 46(2):253-60. PubMed ID: 16022951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model].
    Qiu H; Gao RL; Tang ZR; Meng L; Zhao H; Ruan YM; Zhao H; Yang YJ; Chen JL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):561-4. PubMed ID: 16053797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
    Huang Y; Salu K; Liu X; Li S; Wang L; Verbeken E; Bosmans J; De Scheerder I
    Heart; 2004 Feb; 90(2):195-9. PubMed ID: 14729797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
    Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
    Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
    Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
    Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries.
    Sheiban I; Anselmino M; Moretti C; Biondi-Zoccai G; Galloni M; Vignolini C; Mattoni M; Sciuto F; Omedè P; Trevi GP
    Clin Res Cardiol; 2008 Dec; 97(12):891-8. PubMed ID: 18777002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
    Eshtehardi P; Cook S; Wandel S; Räber L; Wenaweser P; Togni M; Vogel R; Garachemani A; Eberli FR; Lüscher TF; Jüni P; Hess OM; Meier B; Windecker S
    EuroIntervention; 2010 Sep; 6(4):467-74. PubMed ID: 20884434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.